23:11 , Mar 20, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Basal cell carcinoma (BCC) Cell culture and mouse studies suggest inhibition of SRF or its co-activator MLK1 could help treat drug-resistant BCC. In one human and two mouse SMO inhibitor-resistant BCC cell lines, a...